dr. bose on the utility of ruxolitinib in myelofibrosis
Published 4 years ago • 49 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:20
dr. bose on the management of patients with myelofibrosis who progress on ruxolitinib
-
2:09
dr. bose on novel agents under investigation in myelofibrosis
-
1:10
dr. bradley on the utility of ruxolitinib in myelofibrosis and polycythemia vera
-
1:20
dr. bose on treating progression in patients with myelofibrosis
-
8:38
the use of ruxolitinib in myelofibrosis
-
2:04
dr prithviraj bose on treating progression in myelofibrosis
-
5:45
prithviraj bose, md: optimizing ruxolitinib with sotatercept for myelofibrosis
-
6:08
ruxolitinib’s role in treating myelofibrosis
-
1:06
dr prithviraj bose discusses identifying progression in myelofibrosis
-
2:54
unmet needs in myelofibrosis and future outlooks
-
2:22
dr. scherber discusses ruxolitinib failure in myelofibrosis
-
1:01
phase i study of ruxolitinib plus abemaciclib for patients with myelofibrosis
-
2:30
zilurgisertib as monotherapy or in combination with ruxolitinib in patients with mf-related anemia
-
1:12
dr. kuykendall on the approval of fedratinib in myelofibrosis
-
1:52
the role of ruxolitinib in the treatment of early-stage myelofibrosis
-
2:07
real-world use of ruxolitinib in patients with myelofibrosis with anemia or thrombocytopenia
-
4:12
pacritinib for patients with mf across the cytopenic spectrum
-
2:03
dr. mesa on jakarta-2 reanalysis for myelofibrosis
-
5:50
phase i/ii study evaluates zilurgisertib plus or minus ruxolitinib in myelofibrosis